Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Genetic variants in antioxidant genes are associated with diisocyanate-induced asthma.

Yucesoy B, Johnson VJ, Lummus ZL, Kissling GE, Fluharty K, Gautrin D, Malo JL, Cartier A, Boulet LP, Sastre J, Quirce S, Germolec DR, Tarlo SM, Cruz MJ, Munoz X, Luster MI, Bernstein DI.

Toxicol Sci. 2012 Sep;129(1):166-73. doi: 10.1093/toxsci/kfs183. Epub 2012 May 17.

2.

Immune responses to self-antigens in asthma patients: clinical and immunopathological implications.

Liu M, Subramanian V, Christie C, Castro M, Mohanakumar T.

Hum Immunol. 2012 May;73(5):511-6. doi: 10.1016/j.humimm.2012.02.010. Epub 2012 Feb 17.

3.

Hexamethylene diisocyanate asthma is associated with genetic polymorphisms of CD14, IL-13, and IL-4 receptor α.

Bernstein DI, Kissling GE, Khurana Hershey G, Yucesoy B, Johnson VJ, Cartier A, Gautrin D, Sastre J, Boulet LP, Malo JL, Quirce S, Tarlo SM, Langmeyer S, Luster MI, Lummus ZL.

J Allergy Clin Immunol. 2011 Aug;128(2):418-20. doi: 10.1016/j.jaci.2011.03.007. Epub 2011 Apr 13. No abstract available.

4.

Genetics of occupational asthma.

Bernstein DI.

Curr Opin Allergy Clin Immunol. 2011 Apr;11(2):86-9. doi: 10.1097/ACI.0b013e3283449fc9. Review.

PMID:
21325943
5.

Alpha-T-catenin (CTNNA3) gene was identified as a risk variant for toluene diisocyanate-induced asthma by genome-wide association analysis.

Kim SH, Cho BY, Park CS, Shin ES, Cho EY, Yang EM, Kim CW, Hong CS, Lee JE, Park HS.

Clin Exp Allergy. 2009 Feb;39(2):203-12. doi: 10.1111/j.1365-2222.2008.03117.x.

PMID:
19187332
6.

Specific antibodies to diisocyanate and work-related respiratory symptoms in apprentice car-painters.

Dragos M, Jones M, Malo JL, Ghezzo H, Gautrin D.

Occup Environ Med. 2009 Apr;66(4):227-34. doi: 10.1136/oem.2007.038125. Epub 2008 Nov 18.

PMID:
19017707
7.

Altered expression of epithelial junctional proteins in atopic asthma: possible role in inflammation.

de Boer WI, Sharma HS, Baelemans SM, Hoogsteden HC, Lambrecht BN, Braunstahl GJ.

Can J Physiol Pharmacol. 2008 Mar;86(3):105-12. doi: 10.1139/y08-004.

PMID:
18418437
8.

Fifteen-year trends in occupational asthma: data from the Shield surveillance scheme.

Bakerly ND, Moore VC, Vellore AD, Jaakkola MS, Robertson AS, Burge PS.

Occup Med (Lond). 2008 May;58(3):169-74. doi: 10.1093/occmed/kqn007. Epub 2008 Feb 27.

PMID:
18308695
9.

Diisocyanate asthma and gene-environment interactions with IL4RA, CD-14, and IL-13 genes.

Bernstein DI, Wang N, Campo P, Chakraborty R, Smith A, Cartier A, Boulet LP, Malo JL, Yucesoy B, Luster M, Tarlo SM, Hershey GK.

Ann Allergy Asthma Immunol. 2006 Dec;97(6):800-6.

PMID:
17201240
10.

Insulin degrading enzyme and alpha-3 catenin polymorphisms in Italian patients with Alzheimer disease.

Cellini E, Bagnoli S, Tedde A, Nacmias B, Piacentini S, Sorbi S.

Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):246-7. No abstract available.

PMID:
16327352
11.

Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer's disease.

Blomqvist ME, Andreasen N, Bogdanovic N, Blennow K, Brookes AJ, Prince JA.

Neurosci Lett. 2004 Apr 1;358(3):220-2.

PMID:
15039120
12.

Need for monitoring nonspecific bronchial hyperresponsiveness before and after isocyanate inhalation challenge.

Sastre J, Fernández-Nieto M, Novalbos A, De Las Heras M, Cuesta J, Quirce S.

Chest. 2003 Apr;123(4):1276-9.

PMID:
12684321
13.

Regulation of E-cadherin/catenin complex patterns by epidermal growth factor receptor modulation in human lung cancer cells.

Al Moustafa AE, Yen L, Benlimame N, Alaoui-Jamali MA.

Lung Cancer. 2002 Jul;37(1):49-56.

PMID:
12057867
14.

N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk.

Wikman H, Piirilä P, Rosenberg C, Luukkonen R, Kääriä K, Nordman H, Norppa H, Vainio H, Hirvonen A.

Pharmacogenetics. 2002 Apr;12(3):227-33.

PMID:
11927838
15.

Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure.

Piirilä P, Wikman H, Luukkonen R, Kääriä K, Rosenberg C, Nordman H, Norppa H, Vainio H, Hirvonen A.

Pharmacogenetics. 2001 Jul;11(5):437-45.

PMID:
11470996
16.

Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma.

Mapp CE, Beghè B, Balboni A, Zamorani G, Padoan M, Jovine L, Baricordi OR, Fabbri LM.

Clin Exp Allergy. 2000 May;30(5):651-6.

PMID:
10792356
17.

Occupational asthma caused by isocyanates: patterns of asthmatic reactions to increasing day-to-day doses.

Malo JL, Ghezzo H, Elie R.

Am J Respir Crit Care Med. 1999 Jun;159(6):1879-83.

PMID:
10351934
18.

The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates.

Bernstein DI, Korbee L, Stauder T, Bernstein JA, Scinto J, Herd ZL, Bernstein IL.

J Allergy Clin Immunol. 1993 Sep;92(3):387-96.

PMID:
8360389
19.

HLA class II alleles in isocyanate-induced asthma.

Bignon JS, Aron Y, Ju LY, Kopferschmitt MC, Garnier R, Mapp C, Fabbri LM, Pauli G, Lockhart A, Charron D, et al.

Am J Respir Crit Care Med. 1994 Jan;149(1):71-5.

PMID:
8111601
20.

Occupational asthma due to isocyanates.

Mapp CE, Boschetto P, Dal Vecchio L, Maestrelli P, Fabbri LM.

Eur Respir J. 1988 Mar;1(3):273-9.

PMID:
3289963

Supplemental Content

Support Center